SCHEMBL14339490

SCHEMBL14339490

OCC1OCC[C@@H](O)[C@@H]1O

nearest known ligand 0.35

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GBA2 Q9HCG7 1/20 0.35
LGALS3 P17931 3/20 0.34
GBA1 P04062 3/20 0.33
ALDH1A1 P00352 2/20 0.32
TSHR P16473 2/20 0.32
LMNA P02545 2/20 0.32
TDP1 Q9NUW8 1/20 0.32
LGALS1 P09382 2/20 0.31
LGALS9 O00182 1/20 0.31
LGALS8 O00214 1/20 0.31
TXNRD1 Q16881 1/20 0.31
TXNRD3 Q86VQ6 1/20 0.31
TXNRD2 Q9NNW7 1/20 0.31
PYGL P06737 1/20 0.30
GAA P10253 1/20 0.30
MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12083286 1.00 GBA2 (0.35) GBA2LGALS3GBA1ALDH1A1TSHR
SCHEMBL5594313 1.00 GBA2 (0.35) GBA2LGALS3GBA1ALDH1A1TSHR
SCHEMBL7772026 1.00 GBA2 (0.35) GBA2LGALS3GBA1ALDH1A1TSHR
SCHEMBL15145344 1.00 GBA2 (0.35) GBA2LGALS3GBA1ALDH1A1TSHR
SCHEMBL3748632 1.00 GBA2 (0.35) GBA2LGALS3GBA1ALDH1A1TSHR
SCHEMBL13969566 1.00 GBA2 (0.35) GBA2LGALS3GBA1ALDH1A1TSHR
SCHEMBL24246852 1.00 GBA2 (0.35) GBA2LGALS3GBA1ALDH1A1TSHR
SCHEMBL7772022 1.00 GBA2 (0.35) GBA2LGALS3GBA1ALDH1A1TSHR
SCHEMBL22640981 1.00 GBA2 (0.35) GBA2LGALS3GBA1ALDH1A1TSHR
SCHEMBL21479622 1.00 GBA2 (0.35) GBA2LGALS3GBA1ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023028350-A1 THERAPEUTIC COMPOSITIONS AND RELATED METHODS BOYCE THOMPSON INSTITUTE FOR PLANT RESEARCH, INC. (US) 2023-03-02 WO disclosed
EP-3891163-B1 FLUORINATED 4' ALKYLUMBELLIFERYL ALPHA-D-GLUCOPYRANOSIDES, BIOLOGICAL STERILIZATION INDICATORS INCLUDING THE SAME AND METHODS OF USING THE SAME 3M INNOVATIVE PROPERTIES CO (US) 2022-05-18 EP disclosed
WO-2013116200-A1 CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY CERULEAN PHARMA INC. (US) 2013-08-08 WO disclosed
WO-2013025490-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF AUTOIMMUNE AND OTHER DISEASES CERULEAN PHARMA INC. (US) 2013-02-21 WO disclosed
EP-1092721-B1 Chiral glucosides and their use as chiral dopants for the production of cholesteric liquid crystalline compositions BASF AG (DE) 2007-12-19 EP disclosed